138 Notes to the financial statements 30 Other non-current liabilities 2009 2008 m m Accruals and deferred income 124 96 Other payables 481 331 605 427 31 Contingent liabilities At 31st December 2009, contingent liabilities, comprising guarantees, discounted bills and other items arising in the normal course of business, amounted to 150 million 2008 134 million.
At 31st December 2009, 9 million 2008 12 million of financial assets were pledged as collateral for contingent liabilities.
For discussions of tax and legal issues, refer to Note 14, Taxation and Note 44, Legal proceedings.
32 Net debt 2009 2008 Listing exchange m m Current assets: Liquid investments 268 391 Cash and cash equivalents 6,545 5,623 6,813 6,014 Short-term borrowings: 3.25% European Medium Term Note 2009 London Stock Exchange 481 US$ Floating Rate Note 2010 New York Stock Exchange 621 Commercial paper 621 Bank loans and overdrafts 182 426 Loan stock 7 Other loans 1 Obligations under finance leases 40 48 1,471 956 Long-term borrowings: US$ Floating rate Note 2010 New York Stock Exchange 694 3.00% European Medium Term Note 2012 London Stock Exchange 662 718 5.125% European Medium Term Note 2012 London Stock Exchange 1,985 2,154 4.85% US$ US Medium Term Note 2013 New York Stock Exchange 1,548 1,728 4.375% US$ US Medium Term Note 2014 London Stock Exchange 990 1,146 3.875% European Medium Term Note 2015 London Stock Exchange 1,404 5.625% European Medium Term Note 2017 London Stock Exchange 1,100 1,193 5.65% US$ US Medium Term Note 2018 New York Stock Exchange 1,701 1,901 4.00% European Medium Term Note 2025 London Stock Exchange 653 709 5.25% European Medium Term Note 2033 London Stock Exchange 979 979 5.375% US$ US Medium Term Note 2034 London Stock Exchange 308 344 6.375% US$ US Medium Term Note 2038 New York Stock Exchange 1,689 1,888 6.375% European Medium Term Note 2039 London Stock Exchange 693 693 5.25% European Medium Term Note 2042 London Stock Exchange 984 984 Loan stock 8 Bank loans 1 Other loans and private financing 3 Obligations under finance leases 90 88 14,786 15,231 Net debt 9,444 10,173 GSK Annual Report 2009 Financial statements P91P182 Business review P06P53 Governance and remuneration P54P90 Financial statements P91P182 Shareholder information P183P204 139 Notes to the financial statements 32 Net debt continued Current assets Liquid investments are classified as available-for-sale investments.
At 31st December 2009, they included US Treasury notes and other government bonds.
The effective interest rate on liquid investments at 31st December 2009 was approximately 4.6% 2008 approximately 5.5%.
Liquid investment balances at 31st December 2009 earning interest at floating and fixed rates amount to 1 million and 267 million, respectively 2008 1 million and 390 million.
The effective interest rate on cash and cash equivalents at 31st December 2009 was approximately 0.7% 2008 approximately 1.8%.
Cash and cash equivalents balances at 31st December 2009 earning interest at floating and fixed rates amount to 6,372 million and 17 million, respectively 2008 5,520 million and 4 million.
GSKs policy regarding the credit quality of cash and cash equivalents is referred to in Note 41, Financial instruments and related disclosures.
Short-term borrowings Commercial paper comprises a US $10 billion programme, of which $1 billion 621 million was in issue at 31st December 2009 2008 $nil nil, backed up by committed facilities of 364 days duration of $3.9 billion 2.4 billion 2008 $3.9 billion 2.7 billion renewable annually, and liquid investments, cash and cash equivalents as shown in the table above.
The weighted average interest rate on current bank loans and overdrafts at 31st December 2009 was 4.8% 2008 1.59%.
Long-term borrowings At the year-end, GSK had long-term borrowings of 14.8 billion 2008 15.2 billion of which 9.5 billion 2008 9.8 billion falls due in more than five years.
Long-term borrowings repayable after five years carry interest at effective rates between 3.88% and 6.38%.
The repayment dates range from 2015 to 2042.
The average effective interest rate of all notes at 31st December 2009 was approximately 4.9% 2008 approximately 5.0%.
Secured liabilities GSK had no loans secured by charges on non-current and current assets in the year 2008 nil.
The Group has pledged investments in US Treasury Notes with a par value of $103 million 2008 $198 million as security against irrevocable letters of credit issued on the Groups behalf in respect of the Groups self-insurance activity.
Provisions in respect of self-insurance are included within the provisions for legal and other disputes discussed in Note 29, Other provisions.
2009 2008 m m Finance lease obligations Rental payments due within one year 44 53 Rental payments due between one and two years 38 39 Rental payments due between two and three years 26 30 Rental payments due between three and four years 16 17 Rental payments due between four and five years 6 6 Rental payments due after five years 16 9 Total future rental payments 146 154 Future finance charges 16 18 Total finance lease obligations 130 136 Finance lease obligations at 31st December 2009 bearing interest at floating and fixed rates amount to 89 million and 41 million, respectively 2008 98 million and 38 million.
